Drug Type Small molecule drug |
Synonyms Com-19(Aptabio) |
Target |
Action inhibitors |
Mechanism CYBB inhibitors(Cytochrome b-245 heavy chain inhibitors), NOX4 inhibitors(NADPH oxidase 4 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | South Korea | 01 Mar 2025 |